Up-regulated production and activation of the complement system in Alzheimer's disease brain.
about
Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitroMechanism of human immunodeficiency virus-induced complement expression in astrocytes and neuronsCorrelation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI studyPaths reunited: Initiation of the classical and lectin pathways of complement activationUsing animal models to determine the significance of complement activation in Alzheimer's diseaseGenetics ignite focus on microglial inflammation in Alzheimer's diseaseApolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's diseaseAntimicrobial peptides and complement in neonatal hypoxia-ischemia induced brain damageInflammation and Alzheimer's diseaseTranscriptome characterization by RNA-Seq reveals the involvement of the complement components in noise-traumatized rat cochleaeImplication of Complement System and its Regulators in Alzheimer’s DiseaseNeuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's diseaseComplement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist.Cellular and molecular mechanisms of immunomodulation in the brain through environmental enrichment.Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues.Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.Complement receptor 3 (CD11b/CD18) is implicated in the elimination of β-amyloid peptides.Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.Alterations in the complement cascade in post-traumatic stress disorder.Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) diseaseAnti-inflammatory drugs: a hope for Alzheimer's disease?Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's diseaseInflammasomes in neuroinflammation and changes in brain function: a focused review.Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasisCombination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophyActivation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammationComplement gene expression and regulation in mouse retina and retinal pigment epithelium/choroid.Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection.Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.Ablation of CCAAT/Enhancer-Binding Protein Delta (C/EBPD): Increased Plaque Burden in a Murine Alzheimer's Disease ModelTemporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.Generation of C-reactive protein and complement components in atherosclerotic plaques.Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline.Induction of complement proteins in a mouse model for cerebral microvascular A beta depositionAstrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study.Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease.
P2860
Q24321663-BF39BA22-66FB-4F8A-B1CE-105FB8FD7844Q24537408-5F28C9CD-B435-417B-85E2-71ABE1EB071BQ24596820-E7F3B4B4-3BA1-4B82-9D00-8DAEF1EC6CFFQ24646047-41EC7EC0-B046-4066-8890-FB9CACB1BC4BQ24796236-044686F2-D5D7-4C85-A379-5663D0DEF35CQ26781865-96E27157-BFE4-4617-9E9D-19155A1DC5BBQ26822534-1B26EF64-D20E-4346-984D-B42BB2D02239Q26850135-4A8E5155-13A6-4B1D-A5CF-2EA5AF21ACBFQ28138617-F57E081D-A6AE-4D09-9F99-795CAA638C47Q28582262-59CD9FCF-43E3-4FCD-BA75-537BA98ECC8AQ28972502-08385B8E-BC0E-40B7-A944-40F5778B2CBDQ30054419-3D25CE41-24B0-4B71-9468-EA5FF4323A80Q30360671-6C829E64-E7A6-4CBB-A008-05DD2E634062Q30439617-5B996DD3-A946-427A-B6A7-B1EDC76E9453Q30492292-A84F1603-DCE4-469B-8F09-58EDE8A31489Q30494084-32D36840-CC3B-4CAA-80A6-B14358382742Q30665192-AE0A5346-E461-446B-84D6-F2A09FFB2AECQ32001587-5491A98E-F4F8-47BE-816D-4C14C687888DQ33711810-9F0C325A-F563-4E12-B296-520C55DB0B48Q33767961-4A5E4544-F50F-468F-9843-16348863F757Q33769083-B8BD9A5F-EE66-45C0-8FB8-BA93048A91D9Q34074779-A63CF6BB-E1E6-48F7-9F6C-E9D7889B9B4EQ34129473-B472CD1C-5C4D-4E5C-A1B1-B64545C7BB91Q34299338-B21B5065-323F-4E3C-869E-211702D9486AQ34471200-662DCF3E-9D9C-4029-B958-083995305BF3Q34792280-CFE7701C-4210-4977-B213-84EB2279A60CQ34805505-08E96BF2-638F-4AEE-A287-7295FED248AFQ35025065-0CBE2A4C-E776-48A9-BD2B-7AA4E98D8911Q35068037-F0511C8F-D802-429E-AC53-4CD9E30AD245Q35148480-AA1B456F-BE3C-4B02-8985-AAA6968CCEF7Q35191570-A930E592-A2B7-458B-9DF0-8E9647E05A53Q35729769-350F39FB-4AF1-4B0F-9D89-AE81715ED6B7Q35745403-84FC0D5A-D4FB-4911-9086-FDB7FFD5E505Q35746446-B34DA989-A464-4EC7-B242-EE04D72CDC80Q35750345-7F04FD29-AD7B-4FE6-8A05-32485864424DQ35909452-1A13DF1A-CC2C-4E49-B516-F123CA48532DQ36177112-21E684CC-49B6-4478-BFFB-E0536962F930Q36456719-37F3909D-8406-4692-8306-7EB5EAE5DE36Q36740479-45FEA96C-B0C4-4B72-9122-7363E7D41BC1Q36961152-6E45AE2C-7A41-4DD4-848E-80CCB30B7D97
P2860
Up-regulated production and activation of the complement system in Alzheimer's disease brain.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Up-regulated production and ac ...... in Alzheimer's disease brain.
@ast
Up-regulated production and ac ...... in Alzheimer's disease brain.
@en
type
label
Up-regulated production and ac ...... in Alzheimer's disease brain.
@ast
Up-regulated production and ac ...... in Alzheimer's disease brain.
@en
prefLabel
Up-regulated production and ac ...... in Alzheimer's disease brain.
@ast
Up-regulated production and ac ...... in Alzheimer's disease brain.
@en
P2093
P2860
P1476
Up-regulated production and ac ...... in Alzheimer's disease brain.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65340-0
P407
P577
1999-03-01T00:00:00Z